HUM.NYSEHumana INC

Form 4: Humana Director Gordon Smith Acquires Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Humana director Gordon Smith acquired 783 restricted stock units as part of his annual director's fee, and holds 765 other restricted stock units.

Summary

  • Gordon Smith, a director at Humana Inc., has reported the acquisition of 783 restricted stock units.
  • These units were granted as part of his annual director's fee and are deferred until his resignation.
  • The restricted stock units will convert to Humana common stock on a 1-for-1 basis upon his resignation.
  • Smith also holds 765 other restricted stock units, which represent a contingent right to receive one share of Humana common stock.
  • The transactions are exempt under Rule 16b-3(d)(1) & (3) of the Securities Exchange Act of 1934.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to slightly positive as it aligns director interests with the company's performance.

Positives

  • The acquisition of restricted stock units aligns the director's interests with the long-term performance of the company.
  • The deferred nature of the stock units encourages long-term commitment from the director.

Industry Context

This is a standard filing related to director compensation and is common practice for publicly traded companies.

Comparison to Industry Standards

  • Granting restricted stock units to directors is a common practice among publicly traded companies as part of their compensation packages.
  • The vesting and conversion terms are typical for such grants, aligning director interests with shareholder value.
  • Many companies in the healthcare sector, such as UnitedHealth Group and CVS Health, also use similar equity-based compensation for their directors.

Stakeholder Impact

  • The acquisition of restricted stock units by a director has a minor positive impact on shareholders as it aligns the director's interests with the long-term performance of the company.

Key Dates

DateDescription
01/02/2025Date of the transaction where restricted stock units were acquired.
01/03/2025Date of the signature on the Form 4 filing.

Keywords

Humana, restricted stock units, director, Gordon Smith, stock incentive plan, beneficial ownership, Form 4, equity securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.